These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11269647)

  • 1. Implications of oncogenomics for cancer research and clinical oncology.
    Herrmann JL; Rastelli L; Burgess CE; Fernandez EE; Rothberg BE; Rothberg JM; Shimkets RA
    Cancer J; 2001; 7(1):40-51. PubMed ID: 11269647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic cancer syndromes and large-scale gene expression analysis: applications in surgical oncology.
    Liefers GJ; Tollenaar RA; Nakamura Y; van de Velde CJ
    Eur J Surg Oncol; 2001 Jun; 27(4):343-8. PubMed ID: 11417977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer biology: signatures guide drug choice.
    Downward J
    Nature; 2006 Jan; 439(7074):274-5. PubMed ID: 16421553
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel strategies for therapeutic design in molecular oncology using gene expression profiles.
    Ricci MS; el-Deiry WS
    Curr Opin Mol Ther; 2000 Dec; 2(6):682-90. PubMed ID: 11249746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue array technology for translational research. From gene discovery to application].
    Kim WH
    Exp Mol Med; 2001 Apr; 33(1 Suppl):135-48. PubMed ID: 11708321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomics revolution and radiotherapy.
    West CM; Elliott RM; Burnet NG
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):470-80. PubMed ID: 17419040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
    Nishiyama M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of expression genomics for predicting treatment response in cancer.
    Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
    Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer genomics: promises and complexities.
    Zhang W; Labordé PM; Coombes KR; Berry DA; Hamilton SR
    Clin Cancer Res; 2001 Aug; 7(8):2159-67. PubMed ID: 11489789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression-driven diagnostics and pharmacogenomics in cancer.
    Wang Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification of breast cancer genes by combined multiple high throughput analyses.
    Shen D; He J; Chang HR
    Int J Mol Med; 2005 Feb; 15(2):205-12. PubMed ID: 15647832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individuated molecular target chemotherapy].
    Yamamoto W; Endo W; Sato A; Matsukawa M
    Nihon Rinsho; 2002 Jan; 60(1):168-73. PubMed ID: 11808329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAGE and related approaches for cancer target identification.
    Porter D; Yao J; Polyak K
    Drug Discov Today; 2006 Feb; 11(3-4):110-8. PubMed ID: 16533708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.